Drawing for EDOM

USPTO serial 88279910

EDOM

Reviewed by CopyMark Law Group

Reg. 5834050Status 702Registered
Filing date
Status date
Registration date
Aug 13, 2019
Examiner
LEASER, ANDREW C
Law office
POST REGISTRATION

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with EDOM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United States

Goods and services

ClassDescriptionStatusFirst use
003Anti-aging creams; Body scrubs; Eye cream; Face creams; Face and body beauty creams; Facial cleansers; Facial masks; Hair care preparations; Hand creams; Moisturizing creams; Shampoos; Shower and bath gel; Skin toners; Bar soap; Beauty serums; Cosmetic body mud; Non-medicated bath salts; Non-medicated foot cream; Non-medicated anti-aging serum; Non-medicated facial and eye serum containing antioxidantsACTIVESep 18, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 11, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 5, 2024EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Sep 3, 2024PUM1OFFICE ACTION ISSUED POU1—
Sep 3, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 13, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Aug 13, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 20, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 20, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 13, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 28, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 28, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 25, 2019ALIEASSIGNED TO LIE—
Apr 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 10, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Apr 10, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 10, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 10, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 9, 2019DOCKASSIGNED TO EXAMINER—
Feb 20, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 31, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance